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The role of maternal obesity in the
risk of neuropsychiatric disorders
Heidi M. Rivera 1, Kelly J. Christiansen 2 and Elinor L. Sullivan 1, 2*
1Division of Diabetes, Obesity, and Metabolism, Oregon National Primate Research Center, Beaverton, OR, USA,
2Department of Biology, University of Portland, Portland, OR, USA
Recent evidence indicates that perinatal exposure to maternal obesity, metabolic
disease, including diabetes and hypertension, and unhealthy maternal diet has
a long-term impact on offspring behavior and physiology. During the past three
decades, the prevalence of both obesity and neuropsychiatric disorders has rapidly
increased. Epidemiologic studies provide evidence that maternal obesity and metabolic
complications increase the risk of attention deficit hyperactivity disorder (ADHD), autism
spectrum disorders, anxiety, depression, schizophrenia, eating disorders (food addiction,
anorexia nervosa, and bulimia nervosa), and impairments in cognition in offspring.
Animal models of maternal high-fat diet (HFD) induced obesity also document persistent
changes in offspring behavior and impairments in critical neural circuitry. Animals exposed
to maternal obesity and HFD consumption display hyperactivity, impairments in social
behavior, increased anxiety-like and depressive-like behaviors, substance addiction, food
addiction, and diminished cognition. During development, these offspring are exposed
to elevated levels of nutrients (fatty acids, glucose), hormones (leptin, insulin), and
inflammatory factors (C-reactive protein, interleukin, and tumor necrosis factor). Such
factors appear to permanently change neuroendocrine regulation and brain development
in offspring. In addition, inflammation of the offspring brain during gestation impairs
the development of neural pathways critical in the regulation of behavior, such as
serotoninergic, dopaminergic, and melanocortinergic systems. Dysregulation of these
circuits increases the risk of mental health disorders. Given the high rates of obesity
in most developed nations, it is critical that the mechanisms by which maternal obesity
programs offspring behavior are thoroughly characterized. Such knowledge will be critical
in the development of preventative strategies and therapeutic interventions.
Keywords: metabolic programming, attention deficit hyperactivity disorder, autism spectrum disorders,
schizophrenia, mood disorders, eating disorders
Introduction
A third of women in the United States are obese (Ogden et al., 2012). Obesity not only
leads to negative health consequences for the woman, but also for her child. The perinatal
environment plays a crucial role in programming the normal development of a child’s metabolic
Abbreviations: 5-HT, serotonin; ADHD, attention deficit hyperactivity disorder; AgRP, agouti-related peptide; ASD, autism
spectrum disorder; BMI, body mass index; DA, dopamine; GWG, gestational weight gain; HFD, high-fat diet; IL-1β,
interleukin-1β; NHP, nonhuman primate; MC4R, melanocortin receptor subtype 4; POMC, proopiomelanocortin.
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and mental health. Exposure to maternal obesity, excessive
gestational weight gain (GWG), maternal metabolic disorders
(diabetes, hypertension, and pre-eclampsia), and an unhealthy
maternal diet adversely impact the behavior and physiology of
children (Brekke et al., 2007; Olson et al., 2009; Stice et al.,
2011; Maftei et al., 2015). Considering the concomitant rise in
the prevalence of obesity and neuropsychiatric disorders (Boyle
et al., 2011; Olfson et al., 2014), it is critical to understand
the relationship between the two. Importantly, the increase
in neuropsychiatric and neurodevelopmental disorders is likely
due not only to maternal obesity, but also factors such as
advancement in diagnostic tools and increased awareness. It
should also be noted that obesity, excessive weight gain, and
metabolic disorders during pregnancy are likely mediated not
only through direct action on energy balance, but also through
indirect effects of stress and mental health on food intake and
physical activity. Epidemiological studies revealed that maternal
obesity is a risk factor in the development of mental health
disorders. However, due to constraints with studies involving
humans, they failed to provide a causative link. Little is known
about the role of excessive GWG, maternal metabolic disorders,
and an unhealthy maternal diet on the development of mental
health disorders. Animal models of maternal obesity, produced
via high-fat diet (HFD) consumption, showed increased risk of
behaviors associated with mental health disorders in offspring.
Biological mechanisms potentially mediating these behavioral
disorders include elevated systemic levels of nutrients (fatty acids,
glucose), hormones (leptin, insulin), and inflammatory markers
(C-reactive protein, interleukin, and tumor necrosis factor).
These factors pass through the placenta into fetal circulation,
producing permanent changes in offspring neuroendocrine
regulation and neural development. In the developing offspring
brain, inflammation impairs the establishment of neural circuits
critical in regulating behavior, such as the serotoninergic
(5-HT), dopaminergic (DA), and melanocortinergic systems.
Impairments of these circuits increase the risk for developing
mental health disorders.
This review has two main goals. First, we summarize studies
that provide evidence for maternal obesity as a major risk factor
for the development of mental health disorders in offspring. Each
section highlights a different mental health disorder, presenting
the relevant human and animal literature. We focus on the
role of maternal obesity, excessive GWG, maternal metabolic
disorders, and an unhealthy maternal diet on the development of
mental health disorders in offspring, with a special emphasis on
neurodevelopmental and neuropsychiatric disorders (Table 1).
These disorders include attention deficit hyperactivity disorder
(ADHD), autism spectrum disorder (ASD), anxiety, depression,
schizophrenia, substance addiction, eating disorders (such as
food addiction, anorexia nervosa, and bulimia nervosa), and
cognitive impairments. Animal literature examines the role
of maternal obesity (produced via HFD consumption) and
impairments in offspring behavior, utilizing various models
and behavioral assays (Table 2). Second, we discuss potential
mechanisms by which maternal obesity programs behavior by
impairing the development of neural circuitry, including 5-
HT, DA, and melanocortin. The identification of risk factors
that program mental health disorders in offspring, originating
from impairments in the mother’s metabolic intrauterine
environment, will aid in the development of preventative
strategies and therapeutic, dietary interventions.
Evidence from Human and Animal Studies
Indicates that Maternal Obesity Impacts
Offspring’s Risk for Neurodevelopmental
and Neuropsychiatric Disorders
Maternal Obesity as a Risk Factor for ADHD
ADHD is the most common neurodevelopmental disorder in
the United States and is typically diagnosed during childhood
or adolescence. ADHD is characterized by hyperactivity,
cognitive impairments (problems with memory and focus), and
impulsivity. According to the Center for Disease Control and
Prevention, approximately 11% of children were diagnosed with
ADHD in 2011 (Visser et al., 2014). The most recent estimate
indicates that the prevalence of ADHD has risen by 33% (Visser
et al., 2014) from 2003 to 2011. There is a substantial gender
bias in ADHD with boys being twice as likely than girls to be
diagnosed (Visser et al., 2014). Children with ADHD experience
complications including poor academic performance, difficulties
in peer relationships, substance abuse, unintentional injuries,
and increased risk for delinquency (Hurley and Eme, 2004;
Loe and Feldman, 2007). The increasing rate of ADHD and
its comorbidity with other behavioral disorders present major
challenges to the affected families and the nation’s education
and health care systems. Here, we discuss the evidence for
maternal obesity, excessive GWG, maternal metabolic disorders,
and an unhealthy maternal diet as potential risk factors
for ADHD.
Research from three human studies indicates a link between
maternal obesity and ADHD in children (Rodriguez et al., 2008;
Rodriguez, 2010; Chen et al., 2014). Obese mothers had a two-
fold increased risk of having a child with ADHD than their
non-obese counterparts (Rodriguez et al., 2008). In addition,
children of obese and overweight mothers displayed an increase
in the severity of teacher-rated ADHD symptoms (inattention
and difficulty dealing with emotions) than those of normal-
weight mothers (Rodriguez, 2010). More recently, a Swedish
study replicated these findings and demonstrated that obese
and overweight mothers had children with an increased risk
of ADHD (Chen et al., 2014). This association remained after
adjusting for demographics (offspring sex, birth order, and
maternal age). However, when familial factors, such as shared
environment and genetics were controlled for this association
was lost. Future work is needed to fully evaluate the role
of familial factors in the link between maternal obesity and
offspring ADHD risk. Animal research provides support that
maternal obesity increases the risk of behaviors associated with
ADHD.Mousemodels of obesity, induced byHFD consumption,
demonstrated that female offspring display decreased sociability
(a key characteristic of ADHD) in a 3-chamber social interaction
test, while male offspring display hyperactivity in an open field
test (Kang et al., 2014). In summary, these studies provide
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TABLE 1 | Summary of human research demonstrating that maternal obesity increases the risk for mental health disorders.
Child outcome Maternal factor References Study design
ADHD symptomology/Risk Pre-pregnancy BMI Rodriguez et al., 2008 Cohort
Rodriguez, 2010 Cohort
Chen et al., 2014 Cohort
Buss et al., 2012 Cohort
GWG Rodriguez et al., 2008 Cohort
Gestational diabetes & SES Nomura et al., 2012 Cohort
Schmitt and Romanos, 2012 Survey; Cohort
Dietary intake of omega-3 fatty acids Field, 2014 Case-control
ASD risk/Severity of symptoms Pre-pregnancy BMI Krakowiak et al., 2012 Case-control
Reynolds et al., 2014 Cohort
Moss and Chugani, 2014 Cohort
Dodds et al., 2011 Cohort
Bilder et al., 2013 Case-control; Cohort
GWG Dodds et al., 2011 Cohort
Bilder et al., 2013 Case-control; Cohort
Diabetes, hypertension, or pre-eclampsia Krakowiak et al., 2012 Case-control
Dodds et al., 2011 Cohort
Lyall et al., 2012 Cohort
Wallace et al., 2008 Cohort
Anxiety/depression risk Pre-pregnancy BMI Rodriguez, 2010 Cohort
Van Lieshout et al., 2013 Cohort
Colman et al., 2012 Cohort
Schizophrenia risk Pre-pregnancy BMI Jones et al., 1998 Cohort
Schaefer et al., 2000 Cohort
GWG Kawai et al., 2004 Case-control
Pre-eclampsia/hypertension and diuretic treatment Dalman et al., 1999 Cohort
Eide et al., 2013 Cohort
Sorensen et al., 2003 Cohort
Food addiction BMI 5 months post-delivery Rising and Lifshitz, 2005 Cohort
Intake of sweets during pregnancy Brekke et al., 2007 Cohort
Anorexia nervosa/
Bulimia nervosa risk
BMI 6 months post-delivery
Disordered eating
Stice et al., 1999 Cohort
Intake of sweets during pregnancy Lamerz et al., 2005 Survey
Risk of cognitive impairments Pre-pregnancy BMI Hinkle et al., 2012 Cohort
Tanda et al., 2013 Survey; Cohort
Neggers et al., 2003 Survey
Heikura et al., 2008 Cohort
Brion et al., 2011 Cohort
Craig et al., 2013 Case-control
Abbreviations: ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; BMI, body mass index; GWG, gestational weight gain; SES, socioeconomic status.
evidence thatmaternal obesity is a risk factor for the development
of ADHD and increased severity of ADHD symptomology in
children. Studies that are able to elucidate the role of genetics and
shared environment in this association are necessary. Moreover,
the mechanisms by which maternal obesity increases a child’s
ADHD risk, such as epigenetic changes, need to be examined.
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TABLE 2 | Summary of animal research demonstrating that maternal obesity leads to impairments in offspring behavior.
Offspring behavior Maternal factor Reference Species Experiment
Hyperactivity HFD consumption Kang et al., 2014, mouse Open field test
Sociability HFD consumption Kang et al., 2014, mouse 3-chamber social interaction test
Attenuated sociability impairments Choline consumption Langley et al., 2014, mouse 3-chamber social interaction test
Anxiety-like behavior HFD consumption Kang et al., 2014, mouse Open field test
Sullivan et al., 2010, nonhuman primate Novel object test
Bilbo and Tsang, 2010, rat Morris water maze; elevated plus maze
Sasaki et al., 2013, rat Elevated plus maze; Open field test
Depressive-like behavior HFD consumption Can et al., 2012, rat Porsolt swim test
Giriko et al., 2013, rat Porsolt swim test
Substance addiction HFD consumption Bocarsly et al., 2012 , rat Intermittent ethanol access test
Morganstern et al., 2013, rat Operant response to nicotine
Naef et al., 2008, rat Locomotor response to nicotine
Food addiction HFD consumption Bayol et al., 2007, rat Intake test
Vucetic et al., 2010, mouse Food preference test
Naef et al., 2011, rat Operant response to fat
Cognition HFD consumption Tozuka et al., 2010, mouse Barnes maze
Abbreviations: HFD, High-fat diet consumption.
Excessive GWG and maternal metabolic disorders are also
thought to impact the child’s risk of ADHD. Two studies have
examined the role of excessive GWG and risk for ADHD in
children. A 2008 study found that mothers who were overweight
and gained a large amount of weight during pregnancy showed
a two-fold increased risk of their children displaying ADHD
symptoms, such as hyperactivity and inattention (Rodriguez
et al., 2008). However, another study found this association
was lost after adjusting for impaired cognitive function in
children (Buss et al., 2012), suggesting that excessive GWG
also impacts offspring cognitive development and that deficits
in cognition may partially mediate the GWG-ADHD link.
Maternal metabolic disorders are also postulated to be associated
with ADHD risk in children. Two studies have examined the
impact of gestational diabetes mellitus on the development of
ADHD in children (Nomura et al., 2012; Schmitt and Romanos,
2012). Both studies found that children of diabetic mothers
had higher rates of ADHD symptoms. Offspring exposed to
gestational diabetes mellitus had impairments in inattention but
not in hyperactivity/impulsivity scores (Nomura et al., 2012).
In families with low socioeconomic class, gestational diabetes
increased offspring’s risk for ADHD by 14-fold. However, this
study had a relatively small sample size and relied on self-
reported gestational diabetes diagnosis thus should be interpreted
cautiously (Nomura et al., 2012). A second study with a larger
sample size was able to confirm these findings (Schmitt and
Romanos, 2012). The limited and conflicting findings of studies
examining excessive GWG, maternal metabolic disorders, and
risk for ADHDdemonstrate the need for future studies that better
track weight gain and metabolic disorders during pregnancy.
There is limited evidence on the impact of an unhealthy,
maternal diet on offspring ADHD risk. However, recent evidence
indicates that a maternal diet deficient in omega-3 fatty acids
increases risk for ADHD. This case control study identified
deficient omega-3-fatty acid levels as a nutritional risk factor for
ADHD (Field, 2014). Multiple causes for this deficiency were
proposed to originate from either variation in the amount of
fatty acid metabolism genes, differences in the level of fatty
acid intake necessary for normal development between sexes,
impaired placental transport of long-chain polyunsaturated fatty
acids, particularly docosahexaenoic acid and arachidonic acid,
which are critical for the development of the fetal central nervous
system. This deficiency in omega-3-fatty acids may be mediated
through impairment ofmaterno-fetal long chain polyunsaturated
fatty acid transport in women with gestational diabetes (Larqué
et al., 2011). Omega-3-fatty acid supplementation may represent
a promising dietary intervention. However, the degree to which
gestational diabetes affects fatty acid transfer from the mother to
the developing child needs to be clarified.
Maternal Obesity as a Risk Factor for ASD
ASD encompasses a wide spectrum of developmental disorders
characterized by impaired social skills and includes restricted
or repetitive interests and activities. The cognitive abilities of
those with ASD can vary greatly from extremely high functioning
and gifted, to severely challenged. The prevalence of ASD has
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increased 30% over the last decade (Wingate et al., 2014). As
with ADHD, there is a gender bias in ASD diagnosis, with males
being 5 times more likely than females to be diagnosed. ASD
not only places a severe emotional strain on families, but is
an economic burden as well. Importantly, early diagnoses and
interventions are critical as they improve long-term outcomes
and reduce lifetime costs to the patient and family (Horlin et al.,
2014). Here, we will discuss the evidence for perinatal metabolic
and nutritional risk factors for ASD.
Three human studies provide evidence of a link between
maternal obesity and ASD in children (Krakowiak et al., 2012;
Moss and Chugani, 2014; Reynolds et al., 2014). Krakowiak and
colleagues were the first to demonstrate that maternal obesity
increased risk of ASD diagnosis and developmental delay in
children (Krakowiak et al., 2012). This finding was supported
by a study reporting that maternal obesity increased the risk
of ASD diagnosis in toddlers (Reynolds et al., 2014). Maternal
obesity was also linked to a delay in language skills in this
study. Other studies have demonstrated an indirect relationship
where maternal obesity increased the likelihood of low birth
weight, which was associated with a two-fold increased risk
of ASD diagnosis (Moss and Chugani, 2014). In a large-scale
population based study, Dodds et al. observed that maternal
pre-pregnancy weight greater than 90 kg was a risk factor for
offspring developing ASD (Dodds et al., 2011). These findings
were not in agreement with a study by Bilder and colleagues,
where excessive GWG, not pre-pregnancy BMI, increased risk for
ASD in children (Bilder et al., 2013), indicating interplay between
GWG and maternal obesity on a child’s ASD risk. The majority
of studies demonstrate that maternal obesity is a risk factor for
ASD diagnosis and developmental delay in children. However,
these studies are largely underpowered, and several occurred in
non-US populations in the 1970s and 1990s, with obesity being
much less prevalent. Also, most of these studies suffered from
methodological limitations including large attrition (Hinkle et al.,
2013; Moss and Chugani, 2014), sampling biases for control
groups (Stein et al., 2006; Krakowiak et al., 2012), reliance on
parental report to evaluate past exposure and current offspring
diagnostic status (Stein et al., 2006; Hinkle et al., 2012, 2013;Moss
and Chugani, 2014), lack of statistical power (Stein et al., 2006),
and inability to adjust for confounders (Stein et al., 2006; Dodds
et al., 2011). Despite these shortcomings, the results point to an
aversive impact of maternal obesity on developmental outcomes,
including ASD and other delays.
The role of excessive GWG on ASD risk in children has only
been examined by two studies. Dodds et al. showed that GWG
greater than 18 kg presented an increased risk for ASD in children
(Dodds et al., 2011). The analysis of both cohorts in the study
conducted by Bilder et al. demonstrated that GWG of over 11 kg
was associated with risk of ASD in children (Bilder et al., 2013).
Four studies have examined the relationship between maternal
metabolic disorders and the risk for ASD in children. Krakowiak
et al. found positive associations with gestational diabetes,
hypertension, and pre-eclampsia and ASD risk (Krakowiak et al.,
2012). These metabolic disorders were associated with an even
greater risk of developmental delays (Krakowiak et al., 2012).
Diabetes, in particular, was associated with verbal developmental
delay. In a large cohort study, maternal complications, including
gestational diabetes and hypertension, were associated with
an increased risk of ASD in children (Lyall et al., 2012).
Wallace et al. showed that gestational hypertension and pre-
eclampsia, but not gestational diabetes, were associated with
increased severity of ASD symptoms (Wallace et al., 2008). Dodds
et al. showed that gestational diabetes and hypertension were
positively correlated with ASD diagnosis (Dodds et al., 2011).
The findings of the few existing studies demonstrate the need for
future studies to better track weight gain during pregnancy and
the interaction between pre-pregnancy body weight and optimal
GWG need to be examined. Also, the limited evidence that
exists indicates that diabetes and hypertension during pregnancy
may increase the risk for ASD and developmental delays in
children.
To date, two human studies have directly examined the fatty
acid composition of the mother’s diet on the child’s ASD risk.
The first study found that intake of high levels of omega-6
fatty acids, such as linoleic acid, reduced the risk of having a
child with ASD by 34% (Lyall et al., 2013). The second case
control study identified deficient omega-3-fatty acid levels
as a nutritional risk factor for offspring ASD (Field, 2014).
Interactions between pre-existing maternal psychopathology
and breastfeeding were also identified as potential risk factors
for ASD (Field, 2014). In rodent models, maternal HFD
consumption resulted in deficits in social behavior in female
offspring (Kang et al., 2014) and choline supplementation during
pregnancy alleviated deficits in offspring social interaction
(Langley et al., 2014). Further studies investigating the impact of
maternal diet on offspring ASD risk are warranted. Moreover,
the protective effects of supplementation with omega-3 and
omega-6 fatty acids need to be investigated. If initial findings
are supportive, omega-3 and 6 fatty acid supplementation
could be encouraged as a cost-effective prophylactic
for ASD.
Maternal Obesity as a Risk Factor for Anxiety
and Depression
Anxiety and depression are among the most common
neuropsychiatric disorders in children and adolescents in
the United States. Anxiety is diagnosed as persistent worry or
fear that leads to impairment of daily life, whereas depression
is characterized by dysphoria. The prevalence of anxiety and
depression is 8% in children and adolescents and continues
to rise (Eapen and Crncec, 2012). Complications associated
with anxiety and depression, include poor social interactions,
strained familial relationships, and negative self-worth (Dweck
and Wortman, 1982; Strauss et al., 1989; Bernstein et al., 1996;
Masi et al., 1999). Here, we will discuss the evidence for perinatal
metabolic and nutritional risk factors for anxiety and depression.
Research has demonstrated a link between maternal obesity
and the development of anxiety and depression in children and
adolescents, which have been examined in a total of three studies.
Maternal pre-pregnancy BMI increased the risk of disrupted
emotions (e.g., fear and sadness) and has also been associated
with increased internalizing behaviors (behaviors associated with
withdrawal and depression) in children (Rodriguez, 2010; Van
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Lieshout et al., 2013). These findings suggest that maternal
obesity is involved in the disruption of emotions. In support
of this finding, but in a more indirect manner, another group
demonstrated that maternal obesity increases the likelihood
of low or high birth weight (Nohr et al., 2008; Djelantik
et al., 2012; Gavard and Artal, 2014), which is also correlated
with development of anxiety and depression in adolescents
(Colman et al., 2012). Additionally, in adults, a gender bias
has been observed in these disorders with the association
between obesity and anxiety being stronger in women than
men (Desai et al., 2009) suggestive of an interaction between
sex and metabolic hormones. More research is needed to
examine whether a gender bias is also observed in a younger
population. However, it has proven to be difficult to diagnose
children. These children are still developing, thus symptoms
may go unnoticed as they are attributed to developmental
changes. Furthermore, children with anxiety and depression
do not express any physical symptoms further impairing
diagnosis.
Rodent research provides further support that maternal
obesity (induced via HFD consumption) increases anxiety-like
behavior in offspring; however, it disagrees as to the sex affected.
Presently, three major rodent studies exist. The Morris water
maze, commonly used to assess anxiety-like behavior, exploits
a rodents’ natural desire to escape from water. Swim speed
indicates how motivated an animal is to escape, a measure of
stress level. Male HFD offspring displayed more anxiety-like
behavior than females in this test (Bilbo and Tsang, 2010). They
swam faster in the Morris water maze, indicating increased
motivation to escape. In the elevated plus maze, rodents have
an innate tendency to hide from predators by spending most of
their time in the dark and avoiding bright open spaces. Male HFD
offspring spent less time in the open arms of an elevated plus
maze relative to controls, indicating increased anxiety. Female
offspring displayed increased anxiety-like behavior, regardless
of maternal diet, in the Morris water maze and elevated plus
maze. Sex differences can be attributed to the behavioral test
administered. In one study, female offspring made fewer entries
into the open arms of an elevated plus maze, whereas male
offspring spent less time in the center of an open field test (Sasaki
et al., 2013). In another study, female HFD offspring displayed
anxiety-like behavior, as they made less visits to the center of
an open field test, whereas the males were hyperactive (Kang
et al., 2014). Additionally, two rodent studies have indicated that
maternal HFD increases depressive-like behavior, as offspring
spent less time swimming and climbing in the Porsolt swim test
(indicating less escape attempts) (Can et al., 2012; Giriko et al.,
2013). However, these studies only examined male offspring.
Future rodent studies need to use the same maternal diet
composition/duration, behavioral assay, sex and age of offspring
to be able to compare across studies. Despite inconsistencies in
sex, the benefit of using rodent models is they are cost-effective,
yield a large sample size, and provide insight into the mechanism
involved.
Our laboratory has developed a nonhuman primate (NHP)
model of diet-induced obesity. NHPs are an important model
as they develop the full spectrum of metabolic disease, express
complex social behaviors, and have similar development of
the brain as humans. A major strength of our model is that
we can assess the impact of maternal diet and metabolic
status, independently, on the development of mental health
disorders (McCurdy et al., 2009). We found that maternal HFD
consumption and obesity increases anxiety-like behavior in
female offspring, as demonstrated by a greater latency to touch
a potentially threating novel object (Sullivan et al., 2010). Male
HFD offspring displayed increased aggression during the human
intruder test used to assess temperament. There was a gender
bias with females being more prone to anxiety-like behavior and
males being more prone to aggression, which is consistent with
evidence found in humans (Archer, 2006; Desai et al., 2009).
These studies provide initial evidence that maternal diet and
obesity is involved in the development of anxiety and depression
in offspring, specifically with respect to difficulty regulating
emotions. The role of additionalmaternalmetabolic impairments
on the development of anxiety and depression remain
unstudied.
Maternal Metabolic State and Risk for
Schizophrenia
Schizophrenia is a disabling disorder characterized by
hallucinations or delusions, disorganized speech, flat affect,
and impairments in cognition. The prevalence of schizophrenia
is on the rise (Stevens et al., 2014). The majority of studies
demonstrating that maternal metabolic state impacts offspring
risk of developing schizophrenia originate from historical
famine events. Developmental exposure to malnutrition was
first linked to schizophrenia risk in a classic study conducted
on individuals who suffered from the Dutch Hunger Winter in
1944–1945 (Stein et al., 1975). In Western countries, obesity,
instead of famine is believed to impact risk of schizophrenia.
Here, we discuss the evidence for perinatal metabolic factors for
schizophrenia.
Six human studies have indicated a link between maternal
obesity and schizophrenia. A case control study found a 24%
increase in schizophrenia risk for every BMI unit increase during
early pregnancy and 19% during late pregnancy (Kawai et al.,
2004). Two cohort studies reported a two-fold increased risk
for schizophrenia in offspring with an elevated maternal BMI
(Jones et al., 1998; Schaefer et al., 2000). Schaefer et al. examined
a cohort of approximately 19,000 births from 1959 to 1967 in
Alameda County, California. Their findings showed a three-fold
increased risk of schizophrenia with an elevated maternal BMI
(Schaefer et al., 2000). The other study focused on a Finnish
cohort of approximately 11,000 participants either born on or
after 1966 (Jones et al., 1998). Their findings showed a two-
fold increased risk of schizophrenia with an elevated maternal
BMI, though this association was no longer evident after gender,
social class, and age of mother at conception were controlled
for (Jones et al., 1998). It is especially important that maternal
age is controlled for in these studies as advanced maternal age
is associated with increased maternal body weight and increased
risk of offspring developing neurodevelopmental disorders.
These studies provide preliminary evidence that maternal obesity
may be a risk factor for offspring developing schizophrenia.
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Additional cohort studies that examine more ethnically diverse
study populations and control for important socio-demographic
factors are needed to determine the broad translatability of these
findings.
The role of maternal metabolic disorders (gestational
diabetes, hypertension, and pre-eclampsia) and offspring risk
of schizophrenia has been examined in four studies. A
positive association between maternal pre-eclampsia and risk
for offspring schizophrenia was reported in two studies
(Dalman et al., 1999; Eide et al., 2013); with one study
reporting a 2.5-fold risk (Dalman et al., 1999). A positive
association between maternal hypertension and schizophrenia
was demonstrated in a third study (Sorensen et al., 2003).
The risk of schizophrenia increased four-fold in offspring of
mothers with hypertension treated with diuretics (Sorensen
et al., 2003). Importantly, it is unclear if the higher risk is
due to the increased severity of hypertension that required
diuretic treatment or to gestational exposure to the diuretic
itself. Lastly, preliminary evidence indicated that mothers of
offspring with schizophrenia were seven times more likely to
have diabetes during pregnancy. However, due to the small
sample size and high variability between groups this was
not statistically significant (Jones et al., 1998). Despite, a few
studies alluding to an association between altered metabolic
states, like diabetes and pre-eclampisa, and offspring’s risk of
schizophrenia, additional research is needed to fully understand
mechanisms contributing to schizophrenia. Furthermore, no
animal research has been conducted. These studies provide
preliminary evidence for an association between maternal
obesity and schizophrenia. Limited evidence also indicates that
maternal metabolic disorders may be a risk factor for developing
schizophrenia.
Maternal Obesity as a Risk Factor for Substance
Abuse and Addiction
In the United States, substance abuse is a major parental concern.
Often beginning early in life, substance abuse is characterized
by a maladaptive pattern of substance use that causes distress.
Chronic substance abuse can lead to addiction that manifests as
the loss of control over drug intake (binge), negative symptoms if
drug is removed (withdrawal), and constant worry that impairs
daily life (Koob et al., 2008). Notably, two out of three high
school students have consumed alcohol (Johnston et al., 2015).
Further, the prevalence of substance abuse is 8% in adolescents
(Rowe, 2012). This high rate of substance abuse leads to medical
complications ranging from acquisition of sexually transmitted
diseases up to death caused by overdose or accidents (Schulte
and Hser, 2014). Here, we discuss the evidence for maternal
obesity as a risk factor for substance addiction in offspring.
The lack of human studies forces us to rely on the animal
literature.
No single animal model can fully represent human addiction,
rather each experimental animal model mimics a different
aspect of the disease, e.g., acquisition phase (recreational
substance use), escalation phase (substance abuse), extinction
phase (abstinence), and reinstatement phase (relapse) (Robinson,
2004). Using rodent models, three studies have examined the
link between maternal obesity and risk for substance addiction
in offspring. One group utilized an intermittent ethanol-access
schedule adapted from food addiction studies (12 h ethanol
access per day) to induce an ethanol binge (Bocarsly et al.,
2012). Adult offspring from mothers that consumed a HFD
during gestation exhibited an increase in ethanol intake relative
to control offspring, indicating increased susceptibility to ethanol
binging. Employing assays more commonly used in substance
addiction, one group examined the influence of maternal HFD
consumption on operant responses to nicotine (Morganstern
et al., 2013). Maternal HFD offspring displayed enhanced
operant responses to nicotine during acquisition (using fixed-
ratio and progressive-ratio schedules of reinforcement) and
escalation demonstrating increases in the rewarding properties of
nicotine. An unexpected diminished response was found during
reinstatement. This diminished response may be attributed to
the development of tolerance after chronic substance use due
to downregulation of nicotinic receptors. This hypothesis is
supported by previous research that maternal HFD offspring
had a diminished locomotor response to chronic treatment with
the stimulant amphetamine (Naef et al., 2008). However, this
story is not straightforward as maternal HFD offspring also
have a diminished locomotor response to acute amphetamine
treatment. The animal literature provides evidence that an
unhealthy maternal diet impairs the rewarding properties of
substances of abuse in offspring. Further research is needed to
examine why maternal HFD selectively targets addiction phases,
the directionality of the effect, and the underlying mechanisms
involved. The paucity of human studies on substance abuse
and addiction should not be interpreted as a lack of effect.
Additional clinical research is needed to better characterize the
effect of maternal obesity, excessive GWG, maternal metabolic
disorders, and an unhealthy maternal diet on the development
of substance abuse and addiction. This will help assess the
translational utility of animal models involving substance
addiction.
Maternal Obesity as Risk Factor for Food
Addiction
The number of papers published on food addiction has risen
dramatically from 53 articles in 2003 to 279 in 2013, a five-fold
increase. The growing interest in food addiction has been sparked
by ongoing debate as to whether or not it should be classified
as an addiction (Avena et al., 2012; Ziauddeen et al., 2012).
Consequently, only two studies exist in the human literature
that have examined the link between maternal obesity and food
addiction in children and infants. Using a laboratory setting,
one group found that infants of obese mothers had a drive to
overeat food with a high carbohydrate content in comparison to
infants from normal-weight mothers (Rising and Lifshitz, 2005).
However, no differences were observed in the consumption of
food with a high protein or fat content. Another group examined
the influence of a mother’s unhealthy diet during pregnancy on
food intake, food choice, and meal patterns in children (Brekke
et al., 2007). The drive to overeat sweets in children was positively
correlated with the mother’s overconsumption of sweet foods.
Children were introduced to sweets earlier (25 days earlier) and
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were allowed to eat sweets more frequently (more than 1 or 2
times per week) than children with mothers that did not overeat
sweets. These children also consumed less healthy food (fruit
and vegetables). These studies provide evidence that maternal
obesity and diet program a drive to overeat food in offspring.
However, these studies used food frequency questionnaires that
are prone to errors (Kristal et al., 2005). Additional human
studies that examine maternal and offspring diet using 24-
h recall to examine the impact of maternal diet on offspring
food addiction are warranted. More studies are also needed to
investigate the association between maternal obesity, maternal
metabolic disorders, and excessive GWG on food addiction in
offspring.
Evidence from three rodent studies provides further support
that maternal obesity increases the risk of food addiction in
offspring. An earlier study demonstrated that rat offspring
whose dams consumed a “junk food” diet (ranging widely in
content from potato chips to marshmallows), during gestation
and lactation, and who themselves consumed a “junk food”
diet after weaning, had a drive to overeat this same diet in
comparison to control offspring (Bayol et al., 2007). However,
the diversity of ingredients in this “junk food” diet prevents
identification of the specific food(s) mediating this programming
effect. A later study where dams were fed a more controlled-
diet high in fat content, during gestation and lactation, found
that offspring had a drive to overeat palatable food high in
sugar and fat content (Vucetic et al., 2010). Moreover, one
study examined whether maternal HFD alters the rewarding
properties of food using a protocol typically used to study
drug addiction. This study found that maternal HFD offspring
displayed enhanced operant responses to fat (using fixed-ratio
and progressive-ratio schedules of reinforcement), but not to
sucrose (Naef et al., 2011). This is the first study to identify that
an unhealthy maternal diet enhances the rewarding properties of
food. Future studies will be needed to replicate this finding and
to better characterize the addiction phases targeted by maternal
HFD.
Maternal Obesity as Risk Factor for Anorexia and
Bulimia Nervosa
Children and adolescents may suffer from eating disorders, such
as anorexia nervosa and bulimia nervosa. Anorexia nervosa is
characterized by restriction of food intake, low body weight,
and fear of gaining weight. Bulimia nervosa is characterized by
recurring episodes of binge eating and compensatory behavior
to reduce weight gain. A recent study conducted in Australia
asserted that the prevalence of eating disorders is higher than
previously believed (Allen et al., 2013) with a clear gender bias
for females (females = 10–15%, males = 3–4%). Particularly
troubling, eating disorders have the highest mortality rate of all
neuropsychiatric disorders (Harris and Barraclough, 1998). We
briefly discuss two studies that examine the influence of maternal
obesity as a risk factor for eating disorders in children. In a
preliminary study, one group demonstrated that maternal obesity
(at 6 months post-delivery) predicted the onset of inhibited
and secretive eating over the first 5 years of a child’s life
(Stice et al., 1999). This behavior indicated that the children
experienced elevated worry concerning weight gain. In addition,
this group reported that maternal eating patterns (bulimic
symptoms, disinhibited eating, hunger, and body dissatisfaction)
were associated with the onset of secretive eating in children.
Therefore, the children could have modeled their eating patterns
after their mothers. A cross-sectional study conducted in
Germany also found that children whose mothers suffered from
binge eating had a six to seven-fold increased risk of developing
binge and night eating (Lamerz et al., 2005). These studies suggest
that maternal obesity and eating patterns influence the onset
and risk for disordered eating behavior in children. However,
when these studies were conducted standardized tests were not
yet established; thus neither study used standardized assessments
to examine the children’s eating patterns. Future studies should
replicate these experiments using standardized questionnaires,
such as the EatingDisorders Diagnostic Interview later developed
by the same research group [Stice et al. (Rohde et al.,
2015)], to improve reliability and validity. The influence of
excessive GWG, maternal metabolic disorders, and unhealthy
maternal diet on the development of eating disorders remains
unknown. Considering, no animal research has been conducted
on this topic, studies utilizing activity-based anorexia or binge-
eating models should be performed in order to compare with
human studies and elucidate the mechanisms that underlie this
relationship.
Maternal Obesity as Risk Factor for Cognitive
Impairments
Maternal obesity has been associated with cognitive impairments
in offspring. Children of obese mothers were reported to have
decreased cognitive and language scores (Hinkle et al., 2012).
A recent study confirmed this finding by demonstrating that
maternal obesity was associated with a reduction in child’s
reading and math scores on standardized tests after intrauterine,
family background, maternal, and child factors were controlled
for (Tanda et al., 2013). These findings were further supported
by a study by Neggers et al. that demonstrated an association
between maternal obesity and a reduction in offspring IQ in
a low socioeconomic African American population (Neggers
et al., 2003). Also, maternal obesity was linked to increased
incidence of mild intellectual disability in a Finnish cohort
(Heikura et al., 2008). However, a study by Brion and colleagues
did not demonstrate an association between offspring cognitive
test scores and maternal obesity (Brion et al., 2011). Another
study found an association between maternal obesity and
decreased language scores in 8 year old children with obese
mothers, but no cognitive deficits (Craig et al., 2013). These
inconsistencies between human studies likely reflect differences
in demographic factors, obesity prevalence between study
populations, and differences in the scales used and measures
assessed. A more standardized scale would prove beneficial
to assess these cognitive impairments and to compare across
research groups. Animal studies provide support to the notion
that exposure to maternal obesity impairs offspring cognition.
Offspring of mothers that consumed a HFD were associated
with delayed spatial learning using the Barnes maze in young
rats (Tozuka et al., 2010). Additional human studies that
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examine large diverse study populations are needed to fully
examine the impact of maternal obesity on offspring cognition.
Also, further animal studies are warranted that elucidate the
mechanisms by which maternal obesity may decrease offspring
cognition.
Possible Mechanisms by Which Maternal Obesity
Increases Risk for Mental Health Disorders
Inflammation-induced Programming
Obesity is considered a state of chronic inflammation as an
increase in adipose tissue mass results in greater secretion of
inflammatory markers including C-reactive protein, interleukin-
6, interleukin-1β, and tumor necrosis factor-α (Das, 2001)
(Figure 1). The inflammatory state associated with obesity is
postulated to underlie many of the associated metabolic diseases
including cardiovascular disease, heart disease, insulin resistance,
diabetes, and hypertension (Das, 2001). Elevated inflammatory
cytokines are also observed in obese pregnant women and
lead to dysfunction in the endothelium (Stewart et al., 2007)
and placenta (Leung and Bryant, 2000; Nordahl et al., 2008).
Maternal HFD increases the amount of the inflammatory
cytokine, IL-1β, in the NHP hypothalamus (Grayson et al.,
2010). Increased inflammatory factors are associated with
neurodevelopmental [ASD (Goines et al., 2011; Ashwood et al.,
2011a,b) and ADHD (Oades et al., 2010; Oades, 2011)] and
neuropsychiatric disorders [anxiety (Maes et al., 2002; Terness
et al., 2002) and depression (Zanoli et al., 2001; Terness
et al., 2002)]. Mounting evidence indicates that developmental
exposure to elevated pro-inflammatory cytokines influences
brain development. Specifically, circulating pro-inflammatory
cytokine levels impact the development of neural circuits critical
for the regulation of behavior (Das, 2001). Thus, inflammation
is an important potential mechanism by which exposure to
maternal obesity and HFD consumption impairs offspring brain
development and increases risk for mental health disorders.
FIGURE 1 | Potential mechanisms through which maternal obesity,
metabolic state, high-fat diet, and excessive gestational weight gain
may lead to the development of mental health disorders in offspring.
Maternal obesity, metabolic disorders, and high-fat diet impact both
intra-uterine and early post-natal development. Excessive gestational weight
gain impacts intrauterine development. Maternal obesity produces systemic
inflammation (via increased pro-inflammatory cytokines) and dysregulation of
metabolic hormones. These cytokines/hormones cross over into the fetal
circulation via the placenta. During development, enhanced inflammation of
the brain is a major contributor to impairments in neural circuits critical for
regulation of behaviors, such as 5-HT, DA, and melanocortin. A gender bias
has also been observed in the development of mental health disorders,
therefore, sex hormones may also play a role in impairing brain function; the
location of its action is poorly described.
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Sex Hormone-induced Programming
Some of the most dramatic findings in psychopathology are the
marked gender differences in neurodevelopmental and mental
health disorders. However, biological mechanisms mediating
this gender bias have not been clearly defined. Sex hormones
could impact brain function through altered hormones in
the periphery, a direct action on receptors in the brain, or
both. Gender differences in brain development are programmed
by androgen production by the fetal testes during critical
periods of development. In primates, the fetal testes begin
producing androgens at the end of the first trimester, with
production continuing into the second semester, and a surge
at birth (Forest et al., 1973; Gendrel et al., 1980). Prenatal
androgens regulate gene and protein levels of important
transcription factors involved in development, such as forkhead
box protein P2 (Bowers et al., 2014). Supporting a central
effect, sex hormones are known to regulate inflammation in
the brain (Pozzi et al., 2006) and signaling of neural circuits
critical for regulating behavior (Bethea et al., 2002; Al Sweidi
et al., 2012). Androgens also result in sex differences in
immune cells including microglia (Lenz et al., 2013; Lenz
and McCarthy, 2014) and mast cells (Lenz and McCarthy,
2014). Microglia are critical for brain development as they
play an important role in proliferation, synaptogenesis, cell
survival, programmed cell death, and synaptic pruning (Lenz
and McCarthy, 2014). Sex differences are also observed in
inflammatory cytokines and chemokines in the developing
hippocampus, amygdala, and cortex (Schwarz et al., 2012).
We hypothesize that sex differences in the response of the
innate immune cells to maternal obesity-induced inflammation
underlies the observed gender differences in behavior. As
development of the brain circuitry critical in behavioral
regulation are sensitive to inflammatory cytokines (Jarskog
et al., 1997; Ishikawa et al., 2007), we believe that gender
differences in behavior are due to unique inflammatory-induced
changes in the development of this brain circuit (Spinelli et al.,
2010).
Metabolic Hormone-induced Programming
Maternal obesity is associated with gestational diabetes, maternal
hyperglycemia, hyperinsulinemia, and hyperleptinemia (Leung
and Lao, 2000). A pregnancy complicated by maternal obesity
and metabolic disorders exposes the developing offspring
to increased circulating nutrients (fatty acids, glucose), and
metabolic hormones (leptin, insulin). Glucose, but not insulin,
can pass through the blood-placenta-barrier and enter the fetal
circulation (Oken and Gillman, 2003). Consequently, the fetal
pancreas compensates with increased insulin release. Maternal-
fetal transmission of leptin has also been observed in the
circulatory system (Luo et al., 2013). Leptin receptors are widely
distributed in brain regions involved in behavioral regulation
including the cortex, hippocampus, amygdala, thalamus, and
hypothalamus (Couce et al., 1997; Meister, 2000). Leptin has also
been shown to increase inflammatory cytokine secretion andmay
also indirectly influence brain development (Lappas et al., 2005).
Elevated levels of metabolic hormones and nutrients during the
perinatal period alter the development of the neural circuits
critical for the regulation of energy balance and behavior (Harder
et al., 1998; Proulx et al., 2002).
Maternal Obesity Impairs Development of the
Serotonin (5-HT) System
A potential mechanism for the increased risk of mental health
disorders associated with early exposure to maternal obesity is
abnormal development of the 5-HT system. The 5-HT system
is a key player in the regulation of emotion and dysregulation
of the 5-HT system is linked to numerous mental health
disorders. 5-HT plays a crucial role in neural development,
influencing synapse formation, neurogenesis, and the migration
of neurons (Daws and Gould, 2011; Kannan et al., 2011).
We observed a decrease in 5-HT synthesis in NHP offspring
exposed to maternal HFD-induced obesity resulting in increased
anxiety-like behavior in female offspring (Sullivan et al., 2010).
This finding is supported by a rodent study in which rodent
HFD offspring displayed an increase in inhibitory autoreceptors
(known to inhibit 5-HT release) (Peleg-Raibstein et al., 2012).
A reduction in 5-HT production underlies neurodevelopmental
disorders, such as ADHD (Oades et al., 2008) and ASD
(Chugani et al., 1999; Challier et al., 2008), and neuropsychiatric
disorders, including anxiety (Kiyohara and Yoshimasu, 2009)
and depressive disorders (Sullivan et al., 2006; Laucht et al.,
2009; Spindelegger et al., 2009). Moreover, selective serotonin
reuptake inhibitors are a standard treatment for these disorders.
Thus, several lines of evidence indicate that changes in the
development of the 5-HT system are a plausible mechanism
for maternal obesity increasing the risk of neurodevelopmental
and neuropsychiatric disorders in offspring. We hypothesize
that the increased production of inflammatory factors associated
with maternal obesity suppresses the development of the 5-HT
neural circuit. Treatment with pro-inflammatory cytokines, such
as interferon-α, reduces the axonal density of 5-HT neurons
in brain regions critical in behavioral regulation such as the
prefrontal cortex and amygdala (Ishikawa et al., 2007). Also,
pro-inflammatory cytokine treatment reduces the survival of 5-
HT neurons in the rostral raphe and substantia nigra (Jarskog
et al., 1997). Exposure to maternal obesity-induced inflammation
may increase risk for mental health disorders in offspring by
suppressing serotoninergic function.
Maternal Obesity Impairs Development of Reward
Neural Circuitry
The role of maternal obesity on central reward signaling
has only been examined in one study (Stice et al., 2011).
There, normal-weight adolescents with two overweight or obese
parents had increased neural activation of the caudate putamen
and frontal and parietal cortex after consuming a milkshake.
Human research demonstrates that maternal obesity is linked
to impairments in central reward signaling in adolescents. The
role of GWG, maternal metabolic disorders, and an unhealthy
maternal diet on central reward signaling remain unknown.
Existing animal literature agrees with human literature on
maternal obesity impairing central DA signaling in offspring.
In rodent studies, research focuses on the mesolimbic and
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mesocortical DA neural circuit, which includes the ventral
tegmentum, nucleus accumbens, and prefrontal cortex. Maternal
HFD led to abnormal central DA signaling in offspring. Existing
rodent literature is mixed as to the direction of this effect.
Two studies point to maternal HFD potentiating central DA
signaling. Maternal HFD increased protein levels of the rate-
limiting enzyme tyrosine hydroxylase (which increases synthesis
of DA) in the ventral tegmentum (Naef et al., 2008) and
DA release to acute stress in the nucleus accumbens (Naef
et al., 2013a). A second group of studies found maternal
HFD suppressed central DA signaling. Maternal HFD decreased
DA responses in anticipation to food (Naef et al., 2013b)
and expression of tyrosine hydroxylase, dopamine receptor 1
(G protein-coupled receptor that increases DA release), and
dopamine receptor 2 (G protein-coupled receptor that decreases
DA release) mRNA in the nucleus accumbens (Vucetic et al.,
2010). Dopamine receptor 1 and 2 were also decreased in
the prefrontal cortex. We hypothesize that increased maternal
obesity-induced inflammation suppresses development of the
DA neural circuit, as treatment with inflammatory cytokines,
interleukin-6, IL-1β, and tumor necrosis factor-α, decrease the
survival of DA neurons in the substantia nigra (Jarskog et al.,
1997). This inflammation-induced impairment in central DA
signaling is presumably what increases the risk for reward-related
behaviors in offspring.
Maternal Obesity Impairs Development of
Melanocortin Neural Circuit
The melanocortin neural circuit in the arcuate nucleus of
the hypothalamus and the paraventricular nucleus of the
hypothalamus regulates energy intake (Cone, 1999). Alpha-
melanocyte stimulating hormone (a cleavage product of the
proopiomelanocortin gene) inhibits food intake through
activation of melanocortin receptor subtype 3 and melanocortin
receptor subtype 4 (MC4R). In contrast, agouti-related
peptide (AgRP) potentiates food intake through blockade of
melanocortin receptor subtype 3 and MC4R. AgRP is colocalized
with neuropeptide Y. No human literature exists examining the
impact of maternal obesity on central melanocortin signaling
in children. Rodent studies have pointed to maternal HFD
impairing central melanocortin signaling in offspring. However,
findings are inconsistent as to whether POMC or AgRP is
affected and to the direction of this effect. One study found
maternal HFD increased expression of AgRP/neuropeptide Y,
POMC, and MC4R mRNA in the entire hypothalamus (Gupta
et al., 2009), whereas two separate studies found that it decreased
the expression of AgRP/ neuropeptide Y mRNA in the arcuate
nucleus of the hypothalamus and entire hypothalamus (Chang
et al., 2008; Sun et al., 2014). Species differences are apparent
in the ontogeny of this neural circuit. The melanocortin neural
circuit develops as late as the third postnatal week in rodents
(Grove et al., 2003; Grove and Smith, 2003), but during the
third trimester of pregnancy in primates (NHP and humans),
making the melanocortin circuit of primates more vulnerable
to changes in the maternal environment (Koutcherov et al.,
2003; Grayson et al., 2006). Using a NHP model, our laboratory
found that third trimester fetal offspring whose dams consumed
a HFD had decreased expression of AgRP mRNA and protein,
but increased expression of POMC and MC4R mRNA in the
arcuate nucleus of the hypothalamus (Grayson et al., 2010).
Inflammatory mechanisms also appear to lead to impairments in
central melanocortin signaling. In the rodent, IL-1β, decreases
AgRP release and increases POMC release in hypothalamic
explants (Scarlett et al., 2007, 2008). This inflammation-
induced impairment in central melanocortin signaling is
perhaps what increases risk for disordered eating behavior in
offspring.
A Diet High in Omega-3 Fatty Acids Improves Neural
Inflammation and Function
Diets high in omega-3 fatty acids protect against inflammation
in the brain and improve neural function. For instance,
omega-3 fatty acid consumption reduced inflammation-induced
upregulation of the pro-inflammatory markers (interleukin-
6 and tumor necrosis factor-α in microglia (Lu et al.,
2010). A decreased inflammatory state in the brain can
facilitate improvements in central 5-HT signaling. In particular,
consumption of omega-3 fatty acids enhanced 5-HT release
from presynaptic neurons and increased cell membrane fluidity
in postsynaptic neurons, which may alter serotonin receptor
availability in the brain (Patrick and Ames, 2015). Therefore,
this evidence demonstrates that a simple dietary intervention
may improve central 5-HT signaling and mitigate the risk of
developing mental health disorders. Importantly, a reduction in
the amount of maternal omega-3 fatty acids is associated with
increased risk of ADHD and ASD (Field, 2014), indicating that
omega-3 fatty acid supplementation is a promising therapeutic
intervention to ameliorate maternal obesity-induced risk of
mental health disorders.
Conclusion
This review highlights research demonstrating that an unhealthy,
perinatal environment programs various mental health
disorders in offspring with a focus on neurodevelopmental
and neuropsychiatric disorders. Epidemiological research
demonstrates a link between maternal obesity and the
development of mental health disorders, including ADHD,
ASD, anxiety, depression, schizophrenia, eating disorders
(food addiction, anorexia nervosa, and bulimia nervosa), and
cognition. There is no literature demonstrating a link between
maternal obesity and substance addiction, indicating a need
for further research in this area. There is also evidence that
excessive GWG, maternal metabolic disorders, and an unhealthy
maternal diet increase the risk for ADHD, ASD, schizophrenia,
and eating disorders. However, these metabolic conditions
have been poorly characterized in anxiety, depression, and
cognition. Animal research agrees with human studies and
shows that maternal obesity (produced by HFD consumption)
contributes to the development of hyperactivity, decreased
sociability, increased anxiety-like and depressive-like behavior,
substance addiction, food addiction, and decreased cognition
in offspring. Schizophrenia, anorexia nervosa, and bulimia
nervosa have yet to be examined in animals. Animal models
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also provide insight into the mechanisms by which maternal
obesity impacts offspring behavior. Maternal obesity has been
shown to increase fetal exposure to inflammation resulting
in impairments in the development of critical neural circuits
that regulate behavior. Impairments in these neural pathways
appear to lead to the development of mental health disorders in
offspring. Future animal studies need to identify the biological
mechanisms involved and whether they differ depending on
the risk factor. Lastly, observational studies have been primarily
conducted in human research. Future studies should focus
on randomized controlled trials, to determine whether early
dietary interventions prevent the development of mental
health disorders in offspring. Specific dietary interventions, like
omega-3 fatty acid supplementation, provide a cost-effective
means to reduce the prevalence of mental health disorders in
children.
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